Medichem’s Stampa Takes Lead At Medicines For Europe
Elisabeth Stampa Sets Out Priorities As She Takes Over Presidency From Rebecca Guntern
Medichem CEO Elisabeth Stampa has been named as the new president of Medicines for Europe, setting out policy priorities that include bolstering the European API sector and supporting a “green transformation” for manufacturing.
You may also be interested in...
Medicines for Europe has called for the EU’s IPCEI on health to encourage access to manufacturing incentives for APIs and off-patent medicines, which so far have been left out of the initiative.
Efforts are being made across the European off-patent community to bolster the supply chain and ensure access to medicines in Ukraine, industry association Medicines for Europe tells Generics Bulletin. It has urged the EU to take a leading role in coordinating supplies through the HERA emergency response body.
Supply issues around breast cancer treatment tamoxifen in Germany demonstrate the damaging effects of European cost-containment measures, Medicines for Europe has warned, citing an “urgent need to revise unsustainable pricing and tendering policies.”